Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Inhibrx Biosciences, Inc. (INBX) had Operating Cash Flow per Share of $-8.38 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-32.83M |
|
-- |
|
-- |
|
$30.92M |
|
$-30.92M |
|
$-1.91M |
|
$-32.83M |
|
$-32.83M |
|
$-32.83M |
|
$-32.83M |
|
$-32.83M |
|
$-32.83M |
|
$-30.92M |
|
$-30.36M |
|
15.49M |
|
15.49M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$132.83M |
|
$3.73M |
|
$13.65M |
|
$146.48M |
|
$33.80M |
|
$100.56M |
|
$104.69M |
|
$138.49M |
|
$7.99M |
|
$7.99M |
|
$7.99M |
|
14.58M |
|
| Cash Flow Statement Financials | |
$-129.79M |
|
$-0.03M |
|
$101.45M |
|
$152.60M |
|
$124.22M |
|
$-28.38M |
|
$11.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.93 |
|
-- |
|
-- |
|
0.93 |
|
12.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-129.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-410.78% |
|
-410.78% |
|
-22.42% |
|
-30.25% |
|
$0.55 |
|
$-8.38 |
|
|
Operating Cash Flow per Share |
$-8.38 |